Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:10:p3
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 10 (pt 3/4)
Character Range: 448452–451651

preparations containing more than 6% (20 volume) of hydrogen peroxide except in preparations manufactured for, and supplied solely by, registered dental practitioners as part of their dental practice.
ISOPROPYL NITRITE.
JUNIPERUS SABINE [savin(e)] for therapeutic use.
KAMBO.
LEAD COMPOUNDS:

       (a) in anti‑fouling paints except in preparations containing 0.1% or less of lead calculated on the non‑volatile content of the paint; or

       (b) in paints (other than anti‑fouling paints), tinters, inks or ink additives except in preparations containing 0.009% or less of lead calculated on the non‑volatile content of the paint, tinter, ink or ink additive; or

       (c) for human therapeutic use except in preparations containing 10 mg/kg or less of lead.
LIGULARIA DENTATA for therapeutic use.
MELIA AZEDARACH including its extracts and derivatives.
METHANOL in hand sanitiser preparations containing more than 5% methanol.
METHYLDIBROMO GLUTARONITRILE in preparations intended to be in contact with the skin, including cosmetic use.
METHYL METHACRYLATE for cosmetic use except in preparations containing 1% or less of methyl methacrylate as residual monomer in a polymer.
METHYLROSANILINIUM CHLORIDE (formerly known as crystal violet) and the following TRIARYLMETHANE DYES – for use in hair dyes:

       (a) Acid Violet 49; or

       (b) Ethyl Violet; or

       (c) Basic Blue 7; or

       (d) Basic Blue 26 (CI 44045).
NAPHTHALENE (excluding derivatives) in preparations in block, ball, disc, pellet or flake form for domestic use except when enclosed in a device which, in normal use, prevents removal or ingestion of its contents.
OXYPHENISATIN for therapeutic use.
PARAFORMALDEHYDE (excluding its derivatives):

       (a) in oral hygiene preparations containing more than 0.1% of free formaldehyde; or

       (b) in aerosol sprays for cosmetic use containing 0.005% or more of free formaldehyde; or

       (c) in nail hardener cosmetic preparations containing 5% or more of free formaldehyde; or

       (d) in all other cosmetic preparations containing 0.05% or more of free formaldehyde except in preparations containing 0.2% or less of free formaldehyde when labelled with the warning statement:

           CONTAINS FORMALDEHYDE.
PETASITES spp. for therapeutic use.
PHENPROMETHAMINE.
PHENYLENEDIAMINES, including alkylated, arylated, halogenated and nitro derivatives, in preparations for skin colouration, tattooing and dyeing of eyelashes or eyebrows except when included in Schedule 6.
POTASSIUM HYDROXIDE (excluding its salts and derivatives), in liquid or semi‑solid food additive preparations, for domestic use, tHE pH of which is more than 11.5.
n‑PROPYL NITRITE.
PTERIDIUM spp. for therapeutic use.
PULMONARIA spp. for therapeutic use.
SAFROLE for internal therapeutic use except in preparations containing 0.1% or less of safrole.
SANGUINARIA CANADENSIS (bloodroot) in preparations for human use except in preparations containing 0.01% or less of SANGUINARINE.
SENECIO spp. for therapeutic use.
SILICONES for injection or implantation except when included in Schedule 4.
SODIUM HYDROXIDE (excluding its salts and derivatives), in liquid or semi‑solid food additive